Su-Xia Lin
Impact in
-
- Glioma Diagnosis and Treatment
-
- Hippo pathway signaling and YAP/TAZ
Papers in
- Oncology 5
- Viral-associated cancers and disorders 2
- Colorectal Cancer Treatments and Studies 2
-
- Lymphoma Diagnosis and Treatment 4
- Co-authors
- Hong-Yun Zhao (2 shared papers)Hui-Qiang Huang (3 shared papers)Yan Gao (3 shared papers)Fei Xu (1 shared paper)Qiu-Liang Wu (1 shared paper)Xin-Ke Zhang (1 shared paper)Li Zhang (1 shared paper)Jing Zeng (1 shared paper)
In The Last Decade
Su-Xia Lin
9 papers receiving 287 citations
Peers
Comparison fields: 5 of 38
- Genetics 49
- Cell Biology 75
- Pathology and Forensic Medicine 72
- Oncology 104
- Immunology 78
Countries citing papers authored by Su-Xia Lin
This map shows the geographic impact of Su-Xia Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Su-Xia Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Su-Xia Lin more than expected).
Fields of papers citing papers by Su-Xia Lin
This network shows the impact of papers produced by Su-Xia Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Su-Xia Lin. The network helps show where Su-Xia Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Su-Xia Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 78 | |
| 2 | 2011 | 72 | |
| 3 | 2016 | 60 | |
| 4 | 2018 | 18 | |
| 5 | 2015 | 18 | |
| 6 | 2012 | 16 | |
| 7 | 2019 | 14 | |
| 8 | 2014 | 11 | |
| 9 | 2013 | 3 |
About Su-Xia Lin
Su-Xia Lin is a scholar working on Oncology, Pathology and Forensic Medicine, Immunology, Molecular Biology and Otorhinolaryngology, having authored 9 papers that have together received 290 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (4 papers), Viral-associated cancers and disorders (2 papers), Immune Cell Function and Interaction (2 papers), Immune cells in cancer (2 papers), Colorectal Cancer Treatments and Studies (2 papers), Hepatocellular Carcinoma Treatment and Prognosis (1 paper), Epigenetics and DNA Methylation (1 paper) and Head and Neck Cancer Studies (1 paper). The work is most often cited by research in Genetics (49 citations), Cell Biology (75 citations), Pathology and Forensic Medicine (72 citations), Oncology (104 citations) and Immunology (78 citations). Su-Xia Lin has collaborated with scholars based in China and Hong Kong. Frequent co-authors include Hong-Yun Zhao, Hui-Qiang Huang, Yan Gao, Fei Xu, Qiu-Liang Wu, Xin-Ke Zhang, Li Zhang, Jing Zeng, Mian Xie and Yi Xia. Their work appears in journals such as Cell Death Discovery, Diagnostic Pathology, Anti-Cancer Drugs, Journal of Thoracic Oncology and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.